Simplex Trading, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.7 - $1.07 $7,490 - $11,450	-10,701 Reduced 32.86%	21,864 $15,000
Q4 2022 Feb 02, 2023	SELL	$0.61 - $5.06 $21,507 - $178,405	-35,258 Reduced 51.99%	32,565 $29,000
Q3 2022 Nov 04, 2022	BUY	$4.19 - $7.95 $284,178 - $539,192	67,823 New	67,823 $406,000
Q2 2022 Aug 03, 2022	SELL	$2.59 - $4.3 $450 - $748	-174 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.78 - $5.32 $11 - $15	-3 Reduced 1.69%	174 $0
Q4 2021 Feb 23, 2022	BUY	$4.15 - $6.24 $734 - $1,104	177 New	177 $0

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.